Correspondence 0001193125-25-054192 from FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC.
Date: March 13, 2025 · CIK: 0001572616 · Accession: 0001193125-25-054192
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285522
Letter
Re: Fractyl Health, Inc. Amendment No. 1 to Registration Statement on Form S-3 Filed March 13, 2025 File No. 333-285522 To whom it may concern: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Fractyl Health, Inc. (the “ Company ”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-285522) be accelerated by the Securities and Exchange Commission to 4:00 p.m., Washington D.C. time, on March 18, 2025 or as soon as practicable thereafter. The Company requests that we be notified of such effectiveness by a telephone call to Jonathan Sarna of Latham & Watkins LLP at (312) 876-7686 and that such effectiveness also be confirmed in writing.
Fractyl Health, Inc. 3 Van de Graaff Drive, Suite 200 Burlington, MA 01803 March 13, 2025 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Very truly yours,
Fractyl Health, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Fractyl Health, Inc. 3 Van de Graaff Drive, Suite 200 Burlington, MA 01803 March 13, 2025 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Fractyl Health, Inc. Amendment No. 1 to Registration Statement on Form S-3 Filed March 13, 2025 File No. 333-285522 To whom it may concern: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Fractyl Health, Inc. (the “ Company ”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-285522) be accelerated by the Securities and Exchange Commission to 4:00 p.m., Washington D.C. time, on March 18, 2025 or as soon as practicable thereafter. The Company requests that we be notified of such effectiveness by a telephone call to Jonathan Sarna of Latham & Watkins LLP at (312) 876-7686 and that such effectiveness also be confirmed in writing. Very truly yours, Fractyl Health, Inc. By: /s/ Lisa A. Davidson Lisa A. Davidson Chief Financial Officer cc: Sarah Toomey, Fractyl Health, Inc. Nathan Ajiashvili, Latham & Watkins LLP Jonathan Sarna, Latham & Watkins LLP